Frost & Sullivan Publishes Update Coverage Report on Brainsway Ltd.: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018; Mild setback in FDA marketing approval (OCD); Price target remains within the forecast range.

Frost & Sullivan Publishes Update Coverage Report on Brainsway Ltd.: The Company continues to generate consistent growth based on the rental model with sufficient cash available for 2018; Mild setback in FDA marketing approval (OCD); Price target remains within the forecast range.

Equity Research is published in the framework of the Tel Aviv Stock Exchange (TASE) Analysis Program Tel Aviv, 11 April, 2018 – TASE analysis project was launched in 2016 in order to raise the investors’ level of knowledge of TASE listed technology and...